[1]
“Semaglutide-Associated Severe Gastrointestinal Intolerance and Hepatic Granulomas: A Case Report: Semaglutide-associated Hepatic Granulomas”, J Diabesity, vol. 1, no. 1, p. 6, Oct. 2025, doi: 10.66381/jod.2025.003.